MedPath

Vixotrigine

Generic Name
Vixotrigine
Drug Type
Small Molecule
Chemical Formula
C18H19FN2O2
CAS Number
934240-30-9
Unique Ingredient Identifier
QQS4J85K6Y
Background

Vixotrigine has been investigated for the treatment of Bipolar Disorder and Bipolar Depression.

Clinical Trials
Related News

Absorption, Metabolism, and Excretion Study of BIIB074

Phase 1
Completed
Conditions
Neuropathic Pain
Interventions
First Posted Date
2016-04-26
Last Posted Date
2016-06-16
Lead Sponsor
Biogen
Target Recruit Count
6
Registration Number
NCT02751905
Locations
🇺🇸

Research Site, Madison, Wisconsin, United States

Effect of Itraconazole on the Pharmacokinetics of BIIB074

Phase 1
Completed
Conditions
Neuropathic Pain
Interventions
First Posted Date
2016-03-03
Last Posted Date
2016-06-09
Lead Sponsor
Biogen
Target Recruit Count
16
Registration Number
NCT02698267
Locations
🇬🇧

Research Site, Leeds, United Kingdom

Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2015-09-16
Last Posted Date
2017-10-16
Lead Sponsor
Biogen
Target Recruit Count
36
Registration Number
NCT02551497
Locations
🇬🇧

Research Site, Nottingham, United Kingdom

PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers

Phase 1
Completed
Conditions
Trigeminal Neuralgia
Interventions
Drug: Placebo
First Posted Date
2015-02-10
Last Posted Date
2017-10-12
Lead Sponsor
Biogen
Target Recruit Count
32
Registration Number
NCT02359344
Locations
🇬🇧

Parexel International, London, United Kingdom

Crossover Study of CNV1014802 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy

Phase 2
Completed
Conditions
Lumbosacral Radiculopathy
Interventions
Drug: Placebo
First Posted Date
2012-03-22
Last Posted Date
2017-10-13
Lead Sponsor
Biogen
Target Recruit Count
82
Registration Number
NCT01561027
Locations
🇸🇪

Research Site, Stockholm, Sweden

A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia

Phase 2
Completed
Conditions
Trigeminal Neuralgia
Interventions
Drug: Placebo
First Posted Date
2012-02-29
Last Posted Date
2019-01-10
Lead Sponsor
Biogen
Target Recruit Count
67
Registration Number
NCT01540630
Locations
🇬🇧

Professor Joanna Zakrzewska, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy